What is the debt of ABIOMED this year?
ABIOMED has a debt level of -132.82 USD this year.
ABIOMED Debt 2024
ABIOMED Debt
-132.82 USD
ABIOMED Dividend yield
Ticker
ABMD
ISIN
US0036541003
WKN
873886
In 2024, ABIOMED's total debt was -132.82 USD, a -42.92% change from the -232.7 USD total debt recorded in the previous year.
ABIOMED Aktienanalyse
What does ABIOMED do?
Abiomed Inc. is one of the most innovative companies in the medical technology industry. It was founded in 1981 and is headquartered in Danvers, Massachusetts. The company specializes in the development, manufacturing, and marketing of medical devices aimed at saving or improving patients' lives. Abiomed started as a small company focused on implantation technology for cardiac arrhythmias. However, the company soon recognized the need to concentrate on providing solutions for cardiac intensive care. Today, Abiomed is a leader in the field of cardiopulmonary support systems and offers innovative devices to support the heart. Abiomed's business model revolves around leveraging its expertise in medical technology for cardiology interventions and intensive care and bringing innovative products to market. The company has industry experts and doctors on its team who contribute to the development and manufacturing of products. This highest level of professionalism is also reflected in the distribution channels Abiomed utilizes, with a focus on delivering its products to clinics specialized in critical medical interventions. Abiomed is divided into various business segments that concentrate on the medical devices the company offers. One of these segments is the Impella portfolio, which focuses on heart pumps for acute heart failure. These pumps are capable of supporting the heart during cardiological intervention by pumping blood into the heart while artificially ventilating it. The Impella portfolio is recognized as a standard in cardiac intensive care. Another important area for Abiomed is product development. The company heavily invests in researching and developing new products to meet the current demand in cardiology on the market. Abiomed is aware that rapid development of new products can provide a competitive advantage and, therefore, is an essential part of its business model. The technology offered by Abiomed is revolutionary and allows for the treatment of patients with acute heart failure, which was previously difficult or impossible. This is a significant milestone for the company and the healthcare industry in general. Abiomed is aware of its responsibility towards patients, doctors, and hospitals and is continuously working to develop innovative solutions for the healthcare industry. In summary, Abiomed Inc. is a leading company in the medical technology industry that focuses on cardiology intervention and intensive care. The company is innovative and offers products that can save and improve patients' lives. The Impella portfolio, specializing in acute heart failure, is an important part of its business model. Abiomed heavily invests in research and development to consistently provide innovative solutions to its customers. ABIOMED ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding ABIOMED's Debt Structure
ABIOMED's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing ABIOMED's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to ABIOMED’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in ABIOMED’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about ABIOMED Stock
What was the debt of ABIOMED compared to the previous year?
The debt of ABIOMED has increased by -42.92% compared to the previous year dropped.
What are the consequences of high debt for investors in ABIOMED?
High debt can pose a risk for investors of ABIOMED, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of ABIOMED?
Low debt means that ABIOMED has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from ABIOMED affect the company?
An increase in debt of ABIOMED can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of ABIOMED affect the company?
A reduction in debt of ABIOMED can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of ABIOMED?
Some factors that can influence the debt of ABIOMED include investments, acquisitions, operating costs, and revenue development.
Why are the debts of ABIOMED so important for investors?
The debts of ABIOMED are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can ABIOMED take to change the debt?
To change the debt, ABIOMED can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does ABIOMED pay?
Over the past 12 months, ABIOMED paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ABIOMED is expected to pay a dividend of 0 USD.
What is the dividend yield of ABIOMED?
The current dividend yield of ABIOMED is .
When does ABIOMED pay dividends?
ABIOMED pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of ABIOMED?
ABIOMED paid dividends every year for the past 0 years.
What is the dividend of ABIOMED?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is ABIOMED located?
ABIOMED is assigned to the 'Health' sector.
Wann musste ich die Aktien von ABIOMED kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of ABIOMED from 5/14/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/14/2024.
When did ABIOMED pay the last dividend?
The last dividend was paid out on 5/14/2024.
What was the dividend of ABIOMED in the year 2023?
In the year 2023, ABIOMED distributed 0 USD as dividends.
In which currency does ABIOMED pay out the dividend?
The dividends of ABIOMED are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The ABIOMED stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von ABIOMED
Our stock analysis for ABIOMED Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ABIOMED Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
